Your browser doesn't support javascript.
loading
Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy.
Wang, Chen-Yu; Sheng, Chang-Cheng; Ma, Guang-Li; Xu, Da; Liu, Xiao-Qin; Wang, Yu-Ya; Zhang, Li; Cui, Chuan-Liang; Xu, Bing-He; Song, Yu-Qin; Zhu, Jun; Jiao, Zheng.
Afiliación
  • Wang CY; Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Sheng CC; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
  • Ma GL; Department of Clinical Pharmacology, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 222047, China.
  • Xu D; Department of Clinical Pharmacology, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 222047, China.
  • Liu XQ; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, 200041, China.
  • Wang YY; Department of Clinical Pharmacology, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 222047, China.
  • Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Cui CL; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, 100036, China.
  • Xu BH; Department of Medical Oncology, National Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China.
  • Song YQ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, 100036, China.
  • Zhu J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, 100036, China.
  • Jiao Z; Department of Pharmacy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China. jiaozhen@online.sh.cn.
Acta Pharmacol Sin ; 42(8): 1368-1375, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33154554

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article